$25.76+0.22 (+0.86%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD
Baxter International (BAX) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~−1.9%/yr (FY21→FY25), net margin −8.5%.
The four lines that matter · FY21–FY25
Revenue ($M)▲5.7%
11,244.0
FY21→FY25CAGR −1.9%/yr
Net income ($M)▼47.5%
−957.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▼42.1%
332.0
FY21→FY25CAGR −31.8%/yr
Diluted EPS▼47.2%
−1.87
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+1.0%
508.0mn → 513.0mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
Capex
$513.0M
+15.0% YoY in FY25 · 4.6% of revenue.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-9¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 38.9% → 30.1%. Net margin -8.5% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 11,611.0 | 11,244.0 | 10,636.0 | 10,360.0 | 10,057.0 | 12,146.0 | ▲5.7% | −1.9% |
Cost of revenue | 8,117.0 | 7,865.0 | 6,652.0 | 6,210.0 | 6,508.0 | 7,426.0 | ▲18.2% | +1.4% |
Gross profit | 3,494.0 | 3,379.0 | 3,984.0 | 4,150.0 | 3,549.0 | 4,720.0 | ▼15.2% | −8.0% |
Research & development | 519.0 | 518.0 | 590.0 | 518.0 | 450.0 | 531.0 | ▼12.2% | −0.6% |
Selling, general & admin | 2,954.0 | 2,890.0 | 2,967.0 | 2,953.0 | 3,097.0 | 2,845.0 | ▼2.6% | +0.4% |
Total operating expenses | 3,715.0 | 3,687.0 | 3,970.0 | 3,443.0 | 6,394.0 | 3,370.0 | ▼7.1% | +2.3% |
Operating incomefeeds ROC rank | −221.0 | −308.0 | 14.0 | 707.0 | −2,845.0 | 1,350.0 | — | — |
Other income, net | 34.0 | −197.0 | −303.0 | −465.0 | −403.0 | −234.0 | — | — |
Pretax income | −187.0 | −505.0 | −289.0 | 242.0 | −3,248.0 | 1,116.0 | ▼74.7% | — |
Income tax | 432.0 | 395.0 | 37.0 | 61.0 | −135.0 | 83.0 | ▲967.6% | +47.7% |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −723.0 | −957.0 | −649.0 | 2,656.0 | −2,433.0 | 1,295.0 | ▼47.5% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −1.43 | −1.87 | −1.27 | 5.23 | −4.83 | 2.53 | ▼47.2% | — |
Diluted shares (mn) | 520.00 | 513.00 | 510.00 | 508.00 | 504.00 | 508.00 | ▲0.6% | +0.2% |
| Margins | ||||||||
Gross margin13th pct in Healthcare | 30.1% | 30.1% | 37.5% | 40.1% | 35.3% | 38.9% | ▼7.4pp | −8.8pp |
Operating margin | −1.9% | −2.7% | 0.1% | 6.8% | −28.3% | 11.1% | ▼2.9pp | −13.9pp |
Net margin30th pct in Healthcare | −6.2% | −8.5% | −6.1% | 25.6% | −24.2% | 10.7% | ▼2.4pp | −19.2pp |
† TTM = trailing four quarters through 2026-09-30.FY23 effective tax rate was 25% vs a 4% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was −13% vs a 4% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-12 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Baxter International's revenue last fiscal year?
Baxter International reported revenue of $11,244.0M in fiscal 2025, up 5.7% from fiscal 2024.
What was Baxter International's net income?
Baxter International reported net income of −$957.0M in fiscal 2025, a net margin of −8.5%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

